VIA method upstages Pap test in Latin America
This article was originally published in Clinica
Executive Summary
A low-tech, vinegar-based method of screening for cervical cancer should be more widely adopted where Papanicolaou (Pap) testing is not available or under-resourced, says the Pan-American Health Organization (PAHO), in a bid to increase early detection of the condition in parts of Latin America and the wider developing world.
You may also be interested in...
Health And Wellness Trademark Review 3 December, 2019
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
HBW Market News: FTC Ends Another Supplement Scam, Australia Win For ChromaDex, GOED Report, Herbalife
Herbalife opens 9,200 square-foot training facility in China; GOED's latest annual market report, covering 2017-2018, is available; ChromaDex has two-tear exclusivity for nicotinamide riboside chloride in Australia; and A.S. Research arthritis claims for Synovia end in FTC settlement.
Deal Watch: AstraZeneca Continues Divestments By Offloading US/Canada Seroquel Rights
Pharma sells the rights to Germany’s Cheplapharm, which obtained EU/Russia rights in October. Cerecor will acquire Aevi Genomics for $16.1m plus contingent value rights.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: